A targeting vector was designed such that the locus contains the Swedish/London-FAD mutation and a "humanized" Abeta domain sequence in exons 16-18 under the control of the endogenouse APP promoter. A pA sequence and neomycin resistance gene was included in the vector. (J:102542)